share_log

ETRACS 2x Leveraged US Growth Factor TR ETN (NYSEARCA:IWFL) Trading Down 2.2%

ETRACS 2x Leveraged US Growth Factor TR ETN (NYSEARCA:IWFL) Trading Down 2.2%

ETRAS 2 倍槓桿式美國增長因子 TR ETN (紐約證券代碼:IWFL) 交易下跌 2.2%
Defense World ·  2023/02/05 19:11

ETRACS 2x Leveraged US Growth Factor TR ETN (NYSEARCA:IWFL – Get Rating)'s stock price fell 2.2% during trading on Friday . The stock traded as low as $19.82 and last traded at $19.82. 106 shares changed hands during mid-day trading, a decline of 79% from the average session volume of 505 shares. The stock had previously closed at $20.27.

ETRAS 2 倍槓桿式美國增長因子 TR ETN(紐約證券交易代碼:IWFL — 獲得評級)的股價在周五交易期間下跌 2.2%。該股價低至 19.82 美元,最後交易價格為 19.82 美元。106 股在中間交易期間變手,較 505 股平均交易量下跌 79%。該股票之前已收盤 20.27 美元。

ETRACS 2x Leveraged US Growth Factor TR ETN Stock Down 2.2 %

ETRAS 2 倍槓桿式美國增長因子 TR ETN 股票下跌 2.2%

The business has a fifty day moving average of $17.45 and a 200 day moving average of $18.30.

該業務有一個五十天移動平均線 17.45 美元和 200 日移動平均線 18.30 美元。

See Also

另請參閱

  • Get a free copy of the StockNews.com research report on ETRACS 2x Leveraged US Growth Factor TR ETN (IWFL)
  • MarketBeat Week in Review – 1/30 – 2/3
  • Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
  • Zimmer Biomet Beats on Earnings, Growth May be Priced In
  • AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
  • Ford Stock Going Forward After Big Earnings Flop
  • 免費獲取有關 ETRAS 兩倍槓桿美國增長因子 TR ETN(IWFL)的研究報告
  • 市場節拍週的回顧 — 1/30 — 2/3
  • 竹篙股票值得嗎?您應該投資竹篙股嗎?
  • 齊默生物特在盈利上擊敗,增長可能會定價
  • 人工智能軟件製造商 EPAM 擁有最大的技術行業集會
  • 大盈利翻牌後福特股票前進

Receive News & Ratings for ETRACS 2x Leveraged US Growth Factor TR ETN Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ETRACS 2x Leveraged US Growth Factor TR ETN and related companies with MarketBeat.com's FREE daily email newsletter.

接收 ETRAS 2 倍槓桿美國增長因子 TR ETN 每日新聞和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收 ETRASS 2 倍槓桿美國增長因子 TR ETN 及相關公司的最新新聞和分析師評級的簡明每日摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論